Clinical Trial Update: Study With Deferiprone and/or Desferrioxamine in Iron Overloaded Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating deferiprone and/or deferoxamine for iron overload in hemochromatosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemochromatosis

Drugs mentioned

• Desferal (Deferoxamine Mesylate)
• FERRIPROX (deferiprone)

Snippet

Sponsor: Lipomed | Conditions: Hemochromatosis | Phase 3 | Status: COMPLETED